Non-standard Nucleobases for Enhanced DNA Hybridization Specificity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The existing nucleobase pairs in nucleic acid chemistry are limited, leading to undesirable incorporation of modified nucleosides and competition from adventitious DNA/RNA in diagnostic assays, as they only offer two mutually exclusive hydrogen bonding patterns, limiting the specificity and accuracy of nucleic acid interactions.

Innovation Solution

The development of non-standard nucleobase pairs that implement different hydrogen bonding patterns, such as the puDDA:pyAAD patterns, which provide enhanced specificity and stability, allowing for the formation of nucleobase pairs with additional complementary nucleobases, reducing mismatch interactions and improving the accuracy of nucleic acid interactions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If standard nucleobase pairs (A-T, G-C) are used in nucleic acid interactions, then the system is simple and well-understood, but the specificity and accuracy of nucleic acid interactions are limited due to only two mutually exclusive hydrogen bonding patterns

Engineering Contradiction:
Improvespecificity and accuracy of nucleic acid interactionsVSAvoidnumber of nucleobase pair types
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent divides the nucleobase pairing system into multiple distinct hydrogen bonding patterns (first pattern with first set of nucleobases, second pattern with second set of nucleobases), allowing each pattern to be independently optimized for specific diagnostic applications while maintaining overall system manageability

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent modifies the hydrogen bonding parameters by introducing non-standard nucleobases that form alternative hydrogen bonding patterns beyond the conventional Watson-Crick pairing, thereby increasing the number of distinguishable interaction modes without requiring complete redesign of the nucleic acid system

Inventive Principle:
Principle #35Parameter changes

2Reliability

If standard nucleobase pairing rules are used, then the system is simple and established, but competition from adventitious DNA/RNA occurs in diagnostic assays

Engineering Contradiction:
Improvespecificity of diagnostic assaysVSAvoidcompetition from adventitious DNA/RNA
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent introduces asymmetric hydrogen bonding patterns where the first pattern involves specific combinations of nucleobases that do not naturally pair with each other in standard DNA/RNA, creating an asymmetric recognition code that adventitious nucleic acids cannot mimic

Inventive Principle:
Principle #4Asymmetry

Solution Approach 2:

The patent creates synthetic nucleic acid probes that copy the successful Watson-Crick pairing mechanism but use different nucleobase combinations, allowing the probes to bind specifically to target sequences while remaining distinguishable from natural DNA/RNA through the alternative hydrogen bonding pattern

Inventive Principle:
Principle #26Copying

3Strength

If only two hydrogen bonding patterns are used, then the nucleic acid system is simple, but the affinity and stability of nucleic acid interactions are limited

Engineering Contradiction:
Improveaffinity and stability of nucleic acid interactionsVSAvoidnumber of hydrogen bonding patterns
Core Design Contradiction:
StrengthVSDevice complexity

Solution Approach 1:

The patent merges the advantages of simple Watson-Crick pairing with alternative hydrogen bonding patterns by combining them in hybrid nucleic acid structures, where the alternative patterns provide enhanced binding affinity while the overall structure maintains simplicity for practical applications

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent adds a new dimension to nucleic acid interaction by introducing non-standard hydrogen bonding patterns that operate independently from the conventional Watson-Crick pattern, effectively doubling the capacity for specific interactions without requiring more complex three-dimensional structures

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

These non-standard nucleobase pairs enhance the specificity and stability of nucleic acid interactions, reducing competition from adventitious DNA/RNA and improving the accuracy of diagnostic assays by offering additional hydrogen bonding patterns, thereby increasing the affinity for complementary nucleobases.

Implementation Method 1

present to a complementary strand in a Watson-Crick pairing geometry a pattern of hydrogen bonds that is different from the pattern presented by adenine, guanine, cytosine, and thymine

Methodology Applied
Scientific EffectHydrogen bonding: Chemical Bonding

Data Source

PatentUS7741294B1Non-standard nucleobases implementing the isocytidine and isoguanosine hydrogen bonding patterns
Publication Date: 2010.06.22 BENNER STEVEN ALBERT
  • US7741294B1 patent drawing
  • US7741294B1 patent drawing
  • US7741294B1 patent drawing

AI summary

This invention provides compositions of matter that, when incorporated into an oligonucleotide, present to a complementary strand in a Watson-Crick pairing geometry a pattern of hydrogen bonds that is different from the pattern presented by adenine, guanine, cytosine, and thymine. Most specifically, this invention discloses and claims compositions of matter that present the same hydrogen bonding patterns as the isocytidine and isoguanosine nucleobases, but do not have unfavorable tautomeric forms, do not become disassociated from their sugar, and do not make major groove interactions, as much, as easily, or as strongly as isocytidine and isoguanosine.